Jacques Zoungrana
Overview
Explore the profile of Jacques Zoungrana including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
123
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Diallo I, Sarigda M, Diendere E, Sawadogo A, Ouedraogo A, Zoungrana J, et al.
IJID Reg
. 2025 Jan;
14():100517.
PMID: 39845927
Objectives: Less than 25% of people living with HIV (PLWHIV) achieved plasma viral load (PVL) in 2020 in Burkina Faso. This study aimed to identify factors associated with access to...
2.
Eholie S, Ekouevi D, Chazallon C, Charpentier C, Messou E, Diallo Z, et al.
Lancet HIV
. 2024 May;
11(6):e380-e388.
PMID: 38740027
Background: Due to the low number of individuals with HIV-2, no randomised trials of HIV-2 treatment have ever been done. We hypothesised that a non-comparative study describing the outcomes of...
3.
Kabore O, Poda A, Ouattara C, Michodigni F, Belem A, Sawadogo Y, et al.
PLoS One
. 2023 Jun;
18(6):e0286665.
PMID: 37315090
Objective: This study aimed to evaluate the seroprevalence of anti-SARS-CoV-2 IgG and factors associated with the infection among PLWHIV over the first 12 months following the outbreak of COVID-19 in...
4.
Ouattara C, Poda A, Meda Z, Sawadogo Y, Kabore O, Birba E, et al.
BMC Infect Dis
. 2023 Feb;
23(1):108.
PMID: 36814211
Background: An issue of particular concern is the impact of the 2019 novel coronavirus (2019 nCOV) on the people coinfected with the Human Immuno-deficiency Virus (HIV) and/or tuberculosis (TB). Unfortunately,...
5.
Diallo I, Ouedraogo S, Sawadogo A, Ouedraogo G, Diendere E, Zoungrana J, et al.
J Int Assoc Provid AIDS Care
. 2022 Dec;
21:23259582221143675.
PMID: 36474417
HIV2 is endemic in West Africa. In Burkina Faso, its prevalence was estimated at 2%. The aim of this work was to evaluate the follow-up of patients and also to...
6.
Sondo A, Diendere E, Meda B, Diallo I, Zoungrana J, Poda A, et al.
IJID Reg
. 2022 Jun;
1:53-59.
PMID: 35757818
Introduction: Although dengue is the most common arbovirus infection worldwide, studies of severe dengue in Africa are lacking, and risk factors for severe dengue have been insufficiently described. This study...
7.
Kabore N, Cournil A, Poda A, Ciaffi L, Binns-Roemer E, David V, et al.
Kidney Int Rep
. 2022 Mar;
7(3):483-493.
PMID: 35257061
Introduction: G1 and G2 alleles have been associated with kidney-related outcomes in people living with HIV (PLHIV) of Black African origin. No APOL1-related kidney risk data have yet been reported...
8.
Rouamba T, Ouedraogo E, Barry H, Yameogo N, Sondo A, Boly R, et al.
Int J Infect Dis
. 2022 Mar;
118:224-229.
PMID: 35227869
Objectives: Our study aimed to assess the statistical relationship between the use of chloroquine phosphate or hydroxychloroquine plus azithromycin (CQ/HCQ + AZ) and virological recovery, disease worsening, and death among...
9.
Prevalence of human leukocyte antigen HLA-B*57:01 in individuals with HIV in West and Central Africa
Kolou M, Poda A, Diallo Z, Konou E, Dokpomiwa T, Zoungrana J, et al.
BMC Immunol
. 2021 Jul;
22(1):48.
PMID: 34294032
Background: The presence of the human leukocyte antigen HLA-B*57:01 is associated with the development of a hypersensitivity reaction to abacavir (ABC). Limited data exist on HLA-B*57:01 prevalence in individuals with...
10.
Tougouma J, Yameogo A, Yameogo N, Hema A, Hien H, Kambire Y, et al.
Pan Afr Med J
. 2021 May;
38:173.
PMID: 33995780
Introduction: cardiovascular complications have become the 3 cause of death and the 4 reason for hospitalization in HIV-infected patients. The purpose of this study was to determine the frequency of...